Bilimetrix is ​​an innovative startup company in the biomedical sector, born as a spin-off of the University of Trieste.
Since its founding, Bilimetrix aims to increase life expectancy in developing countries, supporting hospitals in preventing kernicterus disease and ensuring that newborns can enjoy a healthy life.
To do so, Bilimetrix experts have conceived Bilistick® System, a Point of Care bilirubin assay for measuring total bilirubin concentration in newborns blood, a key point in risk assessment.
Bilimetrix collaborates with important international foundations for their intervention programs focused on improving the quality of neonatal care in limited resource countries.
Should you be interested in purchasing a Bilistick® System or would like to receive further information about the product and the company, please send us a message by filling out the following form.